我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

心交感神经阻滞对扩张型心肌病二尖瓣和三尖瓣返流的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2005年第6期
页码:
552-554
栏目:
临床研究
出版日期:
2005-12-05

文章信息/Info

Title:
Effects of cardiac sympathetic blockade on mitral and tricuspid regurgitation in patients with dilated cardiomyopathy
作者:
修春红1; 刘凤岐1;  王怀泉2;  沈景霞1
哈尔滨医科大学：１．附属第一医院心内科；２．附属第二医院麻醉科，黑龙江 哈尔滨 150001
Author(s):
XIU Chunhong;  LIU Fengqi;  WANG Huaiquan;  SHEN Jingxia
1.Department of Cardiology, First Affiliated Hospital; 2.Department of Anesthesiology, Second Affiliated Hospital, Harbin Medical University, Harbin,Heilongjiang 150001,China
关键词:
交感神经阻滞; 扩张型心肌病; 二尖瓣返流; 三尖瓣返流
Keywords:
sympathetic blockade;  dilated cardiomyopathy;  mitral regurgitation;  tricuspid regurgitation
分类号:
R542.2
DOI:
-
文献标识码:
A
摘要:
目的 观察心交感神经阻滞对扩张型心肌病二、三尖瓣返流的影响。方法 选取扩张型心肌病患者32名，随机分为对照组(n=14)和治疗组(n=18)。对照组给予常规治疗，治疗组在常规治疗的同时给予心区交感神经阻滞（胸1~5），5 g/L利多卡因每2h经胸段硬膜外导管推注一次（夜间睡眠除外）。于治疗前和１个月后进行常规经胸心脏彩超检查，测量左室舒张末期内径（LVEDD），左房收缩末期内径（LADs），左室射血分数（LVEF），左室短轴缩短率（FS），二尖瓣（MRA）和三尖瓣（TRA）最大的返流面积，计算返流面积占各自心房面积的百分数（二尖瓣MRAP，三尖瓣TRAP）来衡量返流的严重程度。并测量三尖瓣返流速度，计算肺动脉压（PAP），比较治疗组与对照组上述指标的差异。结果 治疗组LADs和LVEDD均较治疗前明显缩小，LVEF和FS较治疗前显著增加。治疗组MRA、TRA、MRAP和TRAP均较治疗前明显减少（MRA 13±4 vs 7±3 mm2，P<0.01；TRA 7.68±3.55 vs 1.75±0.21 mm2，P<0.01）， PAP也明显降低（34±17 vs 15±7 mmHg，1 mmHg=0.133 kPa,P<0.01）。而对照组上述指标治疗前后无明显变化。结论 心交感神经阻滞在明显缩小扩张型心肌病的心腔大小，增强左心室收缩功能的基础上能显著减少二尖瓣和三尖瓣的返流，这为改善扩张型心肌病的预后提供了依据。
Abstract:
AIM To observe the effects of cardiac sympathetic blockade on mitral and tricuspid regurgitation in patients with dilated cardiomyopathy. METHODS Thirty two patients with dilated cardiomyopathy were randomly selected and divided into control group (n=14) and therapy group (n=18). Patients in the control group received routine treatment only with digitalis, diuretics, vasodilators. And patients in the therapy group were given cardiac sympathetic blockade by intermittent injection of 5 g/L lidocaine per 2 h through thoracic epidural catheter except for the night in addition to the routine treatment. All the patients were examined by routine transthoracic echocardiography before and one month after the treatment. Left ventricular enddiastolic diameter(LVEDD), left atrail endsystolic diameter(LADs), left ventricular ejection fraction(LVEF) and left ventricular fractional shortening(FS) were measured. The maximal mitral and tricuspid regurgitation area and ratio of them to left and right atrial endsystolic areas were also measured. The maximal velocity of tricuspid regurgitation and pulmonary arterial pressure(PAP) were calculated. RESULTS In the therapy group, LVEDD and LADs were decreased significantly, and LVEF and FS were increased significantly. MRA, TRA, MRAP, TRAP and PAP were also decreased（MRA 13±4 mm2 vs 7±3 mm2，P<0.01；TRA 7.68±3.55 vs 1.75±0.21 mm2，P<0.01, PAP 34±17 vs 15±7 mmHg,1 mmHg=0.133 kPa,P<0.01）. In the control group, the above parameters were not changed significantly. CONCLUSION Based on the reduction of cardiac size and improvement of left ventricular systolic function, cardiac sympathetic blockade could significantly reduce mitral and tricuspid regurgitation and improve the prognosis of patients with dilated cardiomyopathy.

参考文献/References

［1］ Koelling TM, Aaronson KD, Cody RJ, et al. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction［J］. Am Heart J, 2002,144:524-529.

［2］ Trichon SH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure［J］. Am J Cardiol,2003,91:538-543.

［3］ 刘凤岐，傅世英，修春红，等. 上胸段硬膜外阻滞对扩张型心肌病心腔及收缩功能的影响［J］.中华麻醉学杂志,2001,21：178-179.

［4］ 李竹琴，刘凤岐，孙萍，等. 超声评价原发性扩张型心肌病舒张功能及其与收缩功能的关系［J］. 心脏杂志, 2003,15:357-359.

［5］ Richardson P，McKenna W，Bristow M，et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies ［J］. Circulation, 1996, 93: 841-842.

［6］ Hung J, Kwelling T, Semigran MJ, et al. Usefulness of echocardiographic determined tricuspid regurgitation in predicting eventfree survival in severe heart failure secondary to idiopathic dilated cardiomyopathy or to ischemic cardiomyopathy［J］. Am J Cardiol, 1998, 82: 1301-1303.

［7］ 马文珠，张寄南. 心肌疾病［M］. 南京：江苏科学技术出版社，2000.40.

［8］Otsuji Y, Kumanohoso T, Yoshifuku S, et al. Isolated annular dilation does not usually cause important functional mitral regurgitation［J］. J Am Coll Cardiol, 2002, 39:1651-1656.

［9］ Tolic GA, Korkolis DP, Kopf GS,et al. Revascularization alone(without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and miletomoderate mitral regurgitation［J］. Ann Thorac Surg, 2002,74: 1476-1481.

备注/Memo

备注/Memo:
收稿日期：2004-07-15.基金项目：黑龙江省“十五”科技攻关项目资助（GB01C12603）作者简介：修春红，住院医师，博士生Tel：（0451）53648495382 Email：xch16@126.com
更新日期/Last Update: 2010-01-06